Table 6.
C (n = 10) |
C + DAPA (n = 10) |
DM (n = 10) |
DM + DAPA (n = 10) |
|
---|---|---|---|---|
HOP (mg/g tissue) | 1.43 ± 0.35 | 1.56 ± 0.54 | 1.48 ± 0.28 | 1.50 ± 0.28 |
ICF (%) | 9.41 ± 0.02 | 8.30 ± 0.02 | 8.85 ± 0.02 | 9.88 ± 0.02 |
Diameter (μm) | 17.6 (16.7–18.3) | 15.5 (15.1–16.3) * | 17.1 (15.6–17.8) | 17.6 (15.8–18.1) |
Data are expressed as mean ± standard deviation or median and 25th and 75th percentiles. C: control; C + DAPA: control treated with dapagliflozin; DM: diabetes mellitus; DM + DAPA: DM treated with dapagliflozin; ICF: myocardial interstitial collagen fraction; Diameter: myocyte lower diameter. ANOVA for a 2 × 2 factorial design and Tukey or Kruskal–Wallis and Dunn; * p < 0.05 vs. C.